Clinical and Radiographic Outcomes of Class II Furcation Defects Management Using Propolis: A Case Series
Launched by CAIRO UNIVERSITY · Sep 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to treat class II furcation defects, which are areas where the roots of lower molars are affected by gum disease. The researchers are exploring the use of propolis, a natural substance made by bees, as a cost-effective treatment option that may help with healing bone and wounds in this area. The goal is to find a solution that is accessible and affordable for all patients, compared to traditional methods that can be expensive.
To participate in the trial, individuals should be between 65 and 74 years old, have lower molars with class II furcation defects, and be in good overall health. They should also have minimal plaque and bleeding in their mouths. However, smokers, pregnant or breastfeeding women, and those with severe gum disease are not eligible to join. Participants can expect to receive treatment and be monitored for their progress, helping to advance research on this promising new therapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Inclusion criteria:
- • 1. Lower molars with class II furcation defects.
- • 2. Full mouth plaque score (FMPS )\<20% at baseline.
- • 3. Full mouth bleeding score (FMBS )\<10% at baseline.
- • 4. Systemically healthy.
- • 5. Cooperative patients.
- Exclusion Criteria:
- * Exclusion criteria:
- • 1. Smokers.
- • 2. Pregnancy and lactation.
- • 3. Stage 4 Grade C periodontitis.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, El Manial, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported